Sign Up | Log In | What is SocialPicks?

Novavax Inc (NVAX) Trade Now » Rate NVAX - Discuss NVAX - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

71.5%

Top:

100.0%

Rate NVAX:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

NVAX Analysis & Videos »

... View All >

NVAX: Bull or Bear?

FDA, Clinical Trial News: Pozen, Provectus, Novavax NVAX

73%

-60.41%
in 768 days

Provectus Pharma (OTCBB:PVCT) reported that it expects to hold another end of Phase 2 meeting with FDA to finalize the design of a pending pivotal Phase 3 study under Special Protocol Assessment (SPA) for the local / regional treatment of metastatic melanoma with its lead compound in development, PV-10 (rose bengal for injection). In addition, Phase 2 study data will be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting in early June. <> <font> Pozen (NASDAQ:POZN) and partner AstraZeneca (NYSE:AZN) are awaiting a FDA decision that is expected by the end of April...

Continue reading »

By Mike Havrilla (+1.04% risk: moderate) 04/29/10

42 comments

Bullish on NVAX ... NVAX

62%

-61.33%
in 1090 days

Shares of Novavax, Inc.(Public, NASDAQ:NVAX) continue to rise to $3.00 +0.32 (11.94%) as news of the World Health Organization's increased concern over an "Imminent" Flu Pandemic continues to make headlines. Novavax, with it's VLP technology, was one of the firms mentioned in our Flu Vaccine Initiative report (05/25/08). The other company in that report is Hemispherx BioPharma, Inc (AMEX:HEB)- a loser today- whose shares continue to float in oblivion as the FDA has yet to report whether HEB's Ampligen drug has received approval for CFS. Shares were down (-11.27%) minus $0.32 to $2.52. The...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 06/11/09

5 comments

Will positive news propel Novavax (NVAX) above resistance? NVAX

-69.87%
in 1935 days

Look for a strong boost in shares of Novavax (NVAX) (articles) tomorrow. After the bell, the Baltimore-based vaccine research company announced positive data from tests of its VLP technology against two live virus strains of the avian flu:

"These are the first live-virus challenge data we have presented," said Dr. Rick Bright, Novavax's Vice President of Global Influenza Programs. "These new data are exciting because not only do our VLP vaccines trigger a robust immune response, but we have shown that a single vaccine can protect against two different strains of pandemic influenza." Huma...

Continue reading »

By The Microcap Speculator (-4.59% risk: aggressive) 02/16/07

2 comments

... View All >

People Bullish on NVAX

febcal

Analyst

N/A

about 1 year ago

gakingmaker

Analyst

N/A

about 1 year ago

fotsirko

Analyst

N/A

about 1 year ago

Mike Havrilla

Principal

73%

over 2 years ago

cbruder

Analyst

N/A

over 2 years ago

People Bearish on NVAX

jonock

Analyst

N/A

over 2 years ago

devaia

Analyst

N/A

over 2 years ago

yoosif

Analyst

N/A

over 3 years ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.36%	531
2	Gerald Greene	18.14	+36.28%	286
3	stockmarketfunding.com	17.66	+23.07%	83
4	akiralegrand	13.47	+13.37%	69
5	anup2104	12.13	+132.16%	102

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
ORCL	Oracle Corp
FNM	Fannie Mae
XOM	Exxon Mobil Corp
KO	The CocaCola Company
RIG	Transocean Inc
JNJ	Johnson & Johnson

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

Stop Waiting for the Crash; Use a Regular Investment Plan
by Dan Caplinger (Fool.com) about SPY DJI

... more »

TODAY'S TOP PICKS

USO		Bullish on USO ... by jrmarketing2008
BWLD		Bullish on BWLD ... by jrmarketing2010
DO		Bullish on DO ... by jrmarketing2011
L		Bullish on L ... by jrmarketing2012
AUBN		Bullish on AUBN ... by jrmarketing2008

... more »

StreetInsider.com on NVAX

Novavax (NVAX) Awarded $1.26M DHS Contract

Novavax (NVAX) to Present Top-Line Data from RSV Vaccine Phase I

Novavax to Report Top-Line Results From Phase I Respiratory Syncytial Virus Vaccine Clinical Trial on October 3rd at 5th Vaccine and ISV Annual Global Conference

Form 8-K NOVAVAX INC For: Sep 07

Immunovaccine Announces Appointment of John Trizzino as CEO

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Novavax Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.